Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-3-14
pubmed:abstractText
There is controversy about whether therapy with inhaled corticosteroids (ICSs) modifies the natural history of COPD, characterized by an accelerated decline in FEV(1).
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0012-3692
pubmed:author
pubmed:issnType
Print
pubmed:volume
131
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
682-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17356080-Administration, Inhalation, pubmed-meshheading:17356080-Adrenal Cortex Hormones, pubmed-meshheading:17356080-Aged, pubmed-meshheading:17356080-Cause of Death, pubmed-meshheading:17356080-Female, pubmed-meshheading:17356080-Follow-Up Studies, pubmed-meshheading:17356080-Forced Expiratory Volume, pubmed-meshheading:17356080-Humans, pubmed-meshheading:17356080-Long-Term Care, pubmed-meshheading:17356080-Male, pubmed-meshheading:17356080-Middle Aged, pubmed-meshheading:17356080-Multicenter Studies as Topic, pubmed-meshheading:17356080-Pulmonary Disease, Chronic Obstructive, pubmed-meshheading:17356080-Randomized Controlled Trials as Topic, pubmed-meshheading:17356080-Sex Factors, pubmed-meshheading:17356080-Smoking, pubmed-meshheading:17356080-Smoking Cessation, pubmed-meshheading:17356080-Survival Rate
pubmed:year
2007
pubmed:articleTitle
A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo.
pubmed:affiliation
Head, Program of Epidemiology and Clinical Research, Fundació Caubet-CIMERA Illes Balears, International Centre for Advanced Respiratory Medicine, Recinte Hospital Joan March, Bunyola, Mallorca, Spain.
pubmed:publicationType
Journal Article, Meta-Analysis